Author

L. van’t Veer

Observed names: L. Van't Veer, L. van't Veer

Institution: University of California, San Francisco

Observed institution: University of California, San Francisco

OpenAlex ID: A5126246271

Abstract PD11-03: Predicting treatment outcomes in breast cancer from H&E slides using pathology foundation models with multiple instance learning

2026 · A. Sun, S. Venters, et al. · Clinical Cancer Research

PS4-05-28: Impact of Neoadjuvant Endocrine Therapy on MammaPrint Index in Hormone Receptor-Positive, HER2-Negative MammaPrint Low Risk Early-Stage Breast Cancer

2026 · S. Jacob, C. Wu, et al. · Clinical Cancer Research

Abstract PD13-01: Site(s) of Distant Recurrence after Neoadjuvant Therapy for Patients With High-Risk Early-Stage Breast Cancer (BC): Analysis of Data from the I-SPY2 Trial

2026 · L. Huppert, C. Yau, et al. · Clinical Cancer Research

Works count: 3

Citation count:

H-index:

I10-index: